Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer
2 Bekeken
administrator
07/14/23
Experts discuss the next-generation ALK inhibitors ceritinib and AP26113 as treatments for patients with non-small cell lung cancer.
For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs
Laat meer zien
Facebook Reacties
Geen reacties gevonden